Search - tctmd.com

Displaying 141 - 160 of 422

Sort: Relevancy | Date

News Conference News ESC 2020

Go With Aspirin Alone After TAVR When Anticoagulation Isn’t Needed: POPular TAVI

Todd Neale

August 30, 2020

News Daily News

Systemic Anticoagulation Linked to Lower Mortality in Hospitalized COVID-19

Michael O'Riordan

August 28, 2020

News Daily News

Should Guidelines Support TAVR for Low-Risk Patients? Two Views

L.A. McKeown

August 17, 2020

News Daily News

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

L.A. McKeown

August 10, 2020

News Daily News

COVID-19 Clots Spur Both Arterial, Venous Events in Hospitalized Patients

Caitlin E. Cox

July 24, 2020

News Daily News

STEMI Spectrum in COVID-19 Captured by Multinational Case Series

Caitlin E. Cox

July 08, 2020

News Daily News

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Caitlin E. Cox

June 25, 2020

News Daily News

Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19

Michael O'Riordan

June 08, 2020

News Daily News

‘Relatively Low’ Stroke Incidence in COVID-19, but More Are Cryptogenic

Yael L. Maxwell

May 25, 2020

News Daily News

German COVID-19 Autopsy Data Show Thromboembolism, ‘Heavy’ Lungs

L.A. McKeown

May 11, 2020

News Daily News

Anticoagulants May Aid COVID-19 Patients, NYC Data Suggest

Caitlin E. Cox

May 06, 2020

News Features

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

Shelley Wood

April 29, 2020

News Daily News

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

Michael O'Riordan

April 22, 2020

News Conference News ACC 2020

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

Yael L. Maxwell

March 30, 2020

News Conference News ACC 2020

A-fib Patients Undergoing TAVR Do Better With OAC Alone: POPular TAVI

Todd Neale

March 29, 2020

News Conference News ACC 2020

Genotype-Based P2Y12 Prescribing Post-PCI Falls Short in TAILOR-PCI

Yael L. Maxwell

March 28, 2020

News Daily News

More Support for DOAC-Based Double Therapy After PCI for A-fib Patients

Todd Neale

March 16, 2020

News Industry News

Thrombolex Bashir® Endovascular Catheter First-In-Human (FIH) Trial for Acute Pulmonary Embolism Confirms Early Safety and Feasibility and Impressive Reduction of Clot Burden

March 05, 2020

News Daily News

Preemptive Stents Feasible for TAVR Patients at High Risk for Coronary Occlusion

Yael L. Maxwell

February 14, 2020

News Daily News

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Michael O'Riordan

February 10, 2020

Advertisement

Go With Aspirin Alone After TAVR When Anticoagulation Isn’t Needed: POPular TAVI

Systemic Anticoagulation Linked to Lower Mortality in Hospitalized COVID-19

Should Guidelines Support TAVR for Low-Risk Patients? Two Views

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

COVID-19 Clots Spur Both Arterial, Venous Events in Hospitalized Patients

STEMI Spectrum in COVID-19 Captured by Multinational Case Series

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19

‘Relatively Low’ Stroke Incidence in COVID-19, but More Are Cryptogenic

German COVID-19 Autopsy Data Show Thromboembolism, ‘Heavy’ Lungs

Anticoagulants May Aid COVID-19 Patients, NYC Data Suggest

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

A-fib Patients Undergoing TAVR Do Better With OAC Alone: POPular TAVI

Genotype-Based P2Y12 Prescribing Post-PCI Falls Short in TAILOR-PCI

More Support for DOAC-Based Double Therapy After PCI for A-fib Patients

Thrombolex Bashir® Endovascular Catheter First-In-Human (FIH) Trial for Acute Pulmonary Embolism Confirms Early Safety and Feasibility and Impressive Reduction of Clot Burden

Preemptive Stents Feasible for TAVR Patients at High Risk for Coronary Occlusion

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content